[Pubmed] Maintaining Surgical Principles While Transitioning From Multiport to Single-port Robotic Thymectomy
Posté : 30 oct. 2025 11:00
Ann Thorac Surg Short Rep. 2025 Mar 4;3(3):769-771. doi: 10.1016/j.atssr.2025.02.003. eCollection 2025 Sep.
ABSTRACT
Thymectomy is a treatment option for new-onset or treatment-resistant myasthenia gravis in patients with muscle-type acetylcholine receptor autoantibodies, and it is the standard treatment of early-stage thymomas. However, patients with severe forms, particularly those with titin and ryanodine receptor antibodies, may require long-term immunosuppressive therapy instead. The optimal approach to thymectomy remains debated, with minimally invasive techniques like video-assisted and robot-assisted thoracoscopic surgery offering better perioperative outcomes. Single-port robot-assisted thymectomy has emerged as a safe alternative, allowing a single subxiphoid incision and affording the inherent benefits of the robotic platform. This study describes our approach to single-port robot-assisted thymectomy using a subxiphoid incision.
PMID:41163855 | PMC:PMC12559587 | DOI:10.1016/j.atssr.2025.02.003
Source: https://pubmed.ncbi.nlm.nih.gov/4116385 ... 22+67771e2